Get the Stockscreener App
0.00
100.00%
-3.21
Qualigen Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$3.21
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$6.53M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
0.00
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$8.81
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
0.00 | 6.53M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
Is Qualigen Therapeutics Inc. (7R90) stock a top pick for value investorsQuarterly Performance Summary & Precise Swing Trade Alerts - Newser
Why Qualigen Therapeutics Inc. (7R90) stock attracts HNW investors2025 Winners & Losers & Verified Technical Signals - Newser
Will Qualigen Therapeutics Inc. stock outperform Nasdaq indexTrade Analysis Summary & Daily Profit Focused Stock Screening - Newser
Aug PostEarnings: Can Qualigen Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Analyst Calls & Community Consensus Trade Alerts - BỘ NỘI VỤ
AIxCrypto Holdings (NASDAQ: AIXC) plans 18.1M-share resale amid pivot to crypto and oncology - Stock Titan
Can Qualigen Therapeutics Inc. (7R90) stock retain market dominanceProfit Target & Daily Oversold Bounce Ideas - Newser
Will Qualigen Therapeutics Inc. stock attract more institutional investorsWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Why Qualigen Therapeutics Inc. (7R90) stock is a strong analyst pickJuly 2025 Catalysts & Low Risk Growth Stock Ideas - Newser
Why Qualigen Therapeutics Inc. (7R90) stock could be next leaderWeekly Trade Report & Low Drawdown Momentum Ideas - Newser
Growth Value: Can Qualigen Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Investment Review & AI Based Buy and Sell Signals - BỘ NỘI VỤ
Is Qualigen Therapeutics Inc a good long term investmentSector Leadership Analysis & Minimal Investment Portfolio - earlytimes.in
Qualigen to invest in NanoSynex, stock tumbles 21% - MSN
Why Is Qualigen Therapeutics’ Stock Surging Nearly 300% Premarket? - MSN
Can Qualigen Therapeutics Inc. stock outperform in 2025 bull marketEarnings Performance Report & Accurate Technical Buy Alerts - moha.gov.vn
What analysts say about Qualigen Therapeutics Inc 7R90 stockCurrency Fluctuation Impact & Exceptional Return Capital - earlytimes.in
What is the current Price Target and Forecast for AIXCRYPTO HLDGS (AIXC) - Zacks Investment Research
AIXCAIxCrypto Holdings Inc Stock Price and Quote - Finviz
AIxCrypto Holdings Regains Nasdaq Compliance After Issue - The Globe and Mail
AIxCrypto Holdings Inc (AIXC) Stock Earnings Transcripts - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
AIxCrypto Holdings Rebrands, Unveils New Strategy - The Globe and Mail
AIXC (AIxCrypto Holdings) Sale Of Business : $0.00 Mil (TTM As of Sep. 2025) - GuruFocus
AIxCrypto Holdings Inc (NAS:AIXC) Stock News, Headlines & Updates - GuruFocus
[8-K] Qualigen Therapeutics, Inc. Reports Material Event | QLGN SEC FilingForm 8-K - Stock Titan
AIXC Stock Price and Chart — BOATS:AIXC - TradingView
Is Qualigen Therapeutics Inc. (7R90) stock worth holding before Fed meetingJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Is Qualigen Therapeutics Inc. stock supported by innovation pipeline2025 Performance Recap & Risk Controlled Daily Plans - newser.com
QUALIGEN THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - MarketScreener
AIXC: AIXCRYPTO HLDGSFull Company Report - Zacks Investment Research
Faraday Future Completes Formation of “FFAI+AIXC” Dual-Flywheel, Dual-Bridge, and Dual-Listed Company System; Its Majority Owned Crypto Company Renamed as AIxCrypto (Nasdaq: AIXC) - markets.businessinsider.com
Faraday Future Completes Formation of 'FFAI+AIXC” Dual-Flywheel, Dual-Bridge, and Dual-Listed Company System; Its Majority Owned Crypto Company Renamed as AIxCrypto (Nasdaq: AIXC) - The Manila Times
Faraday Future Advances Dual-Listed Framework with AIxCrypto Holdings Inc. Name Change and Strategic Initiatives - Quiver Quantitative
Faraday Future Completes Formation of “FFAI+AIXC” - GlobeNewswire
Aixcrypto Holdings Inc appoints Jie Sheng as chairman of boardSEC filing - MarketScreener
AIxCrypto rebrands from Qualigen, unveils three-part strategy By Investing.com - Investing.com Nigeria
Qualigen Therapeutics Rebrands to AIxCrypto Holdings - MSN
AIxCrypto rebrands from Qualigen, unveils three-part strategy - Investing.com
What consensus target says about Qualigen Therapeutics Inc. (7R90) stockEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Can Qualigen Therapeutics Inc. (7R90) stock deliver strong annual returnsJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Is Qualigen Therapeutics Inc. (7R90) stock supported by strong fundamentalsWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - newser.com
Is Qualigen Therapeutics Inc. (7R90) stock expanding market penetrationGap Down & Low Drawdown Momentum Ideas - newser.com
How Qualigen Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Will Qualigen Therapeutics Inc. (7R90) stock beat international competition2025 Analyst Calls & AI Enhanced Execution Alerts - newser.com
Qualigen Therapeutics, Inc. will Change its Name to AIxCrypto Holdings, Inc - MarketScreener
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):